Overview
- The Medicare GLP‑1 Bridge Program, which began July 1, lets eligible Medicare beneficiaries obtain certain GLP‑1 weight‑loss drugs for $50 a month through Dec. 31, 2027.
- CVS on Wednesday cut its MinuteClinic virtual visit to $29, added same‑day pickup of all FDA‑approved GLP‑1s at roughly 9,000 stores, and said it will show transparent pricing for Eli Lilly’s Zepbound and Foundayo in its app by early Q4 2026.
- Amazon Pharmacy said it will offer the $50 fills to eligible Medicare patients and will automate eligibility checks, prior authorization and billing while providing home delivery and in‑store pickup to speed fulfillment.
- Retailers are using clinics, pharmacists and digital tools to simplify starts and refills by automating prior authorizations, displaying cash and insured prices, and offering same‑day fulfillment to cut administrative friction for patients.
- For patients this means much lower out‑of‑pocket costs and simpler access to care, and for the market it could pressure commercial pricing, change how manufacturers and insurers handle coupons, and shift where Americans obtain chronic weight‑management treatment.